Kidney function may affect new drug levels
NCT ID NCT07227922
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looks at how the drug clofutriben is processed in people with moderate kidney impairment compared to those with normal kidneys. Sixteen adults will receive a single dose, and researchers will measure drug levels in the blood. The goal is to see if kidney function changes how the drug behaves, which helps guide future dosing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States